Sherron Rogers - Nov 14, 2024 Form 4 Insider Report for Syra Health Corp (SYRA)

Role
Director
Signature
/s/ Deepika Vuppalanchi, as Attorney-in-Fact for Sherron Rogers
Stock symbol
SYRA
Transactions as of
Nov 14, 2024
Transactions value $
$0
Form type
4
Date filed
11/18/2024, 05:07 PM
Previous filing
Oct 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYRA Stock Options Award $0 +11.6K $0.00 11.6K Nov 14, 2024 Class A Common Stock 11.6K $0.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued pursuant to the Issuer's 2022 Omnibus Equity Incentive Plan and vest as follows: (i) 25% of the options vested immediately on the date of grant and (ii) the balance of the options shall vest in 12 equal monthly installments.